Expected earnings - CSL Ltd. ADR
Source: US Earnings Reports
CSL Ltd. ADR (CSLLY) is expected to report for Q4 2025
CSL Ltd. ADR
NASDAQ: CSLLY
CSLLY Trading
-1.05% G/L:
$24.49 Last:
58,704 Volume:
$24.82 Open:
CSLLY Latest News
March 09, 2026 11:01:00 am
CSL announces expansion of Illinois plasma therapy manufacturing facility
March 06, 2026 09:00:00 am
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
January 27, 2026 02:06:00 pm
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
CSLLY Stock Data
$59,010,931,430
958,728,992
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Prakville Victoria Austra
